IP Library › Granted Patent US 11,383,079
Granted Patent B2
US 11,383,079 · App. 16/722,470 · Granted Jul 12, 2022

Activation fixation lead for cardiac conductive system pacing

Inventors: Lili Liu (St Paul, MN); Arthur J. Foster (Blaine, MN); Matthew J. Miller (Stillwater, MN)
Assignee: Cardiac Pacemakers, Inc.
A61N1/0573A61N1/362A61N2001/058
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,383,079
App. No.
16/722,470
Granted
Jul 12, 2022
Kind
B2
Abstract

Various aspects of the present disclosure are directed toward apparatuses, systems, and methods that include an implantable lead. The lead may include a taper or tapered portion and a fixation helix both configured to embed within tissue. In addition, the apparatuses, systems, and methods may include a guide wire configured to obtain and record signals from the heart tissue and facilitate placement of the fixation helix.

Claims (11)

1. An implantable lead for pacing a left or right bundle branch of a patient's heart, the implantable lead comprising:

an elongate body extending between a proximal end and a distal end and including at least one lumen extending between the proximal end and the distal end, the distal end of the elongate body configured to embed within heart tissue and including a tapered portion reducing the elongate body in diameter with a minimum diameter of the tapered portion at the distal end and a maximum diameter of the tapered portion being equal to a maximum outer diameter of the elongate body;

a fixation helix having an outer diameter and the fixation helix extending from distally from the at least one lumen and configured to rotate and therefore translate relative to the elongate body;

wherein the minimum diameter of the tapered portion is equal to the outer diameter of the fixation helix; and

an electrode structure located proximally of and spaced from the tapered portion of the elongate body by a distance of between 3 mm and 10 mm.

2. The implantable lead of claim 1 , wherein the tapered portion facilitates penetration into the heart tissue.

3. The implantable lead of claim 1 , wherein the fixation helix is configured to extend beyond the distal end of the elongate body by between 2 mm and 4 mm.

4. The implantable lead of claim 1 , further comprising a wire having a length to pass from the proximal end of the elongate body and extend outwardly from the distal end of the elongate body and configured to obtain and record signals from the heart tissue.

5. The implantable lead of claim 4 , wherein a distal end of the wire being configured to penetrate the heart tissue and facilitate placement of the fixation helix in the heart tissue.

6. The implantable lead of claim 4 , further comprising the electrode structure arranged near the distal end of the elongate body, and wherein the fixation helix and the electrode are configured to pace the heart tissue and the wire is configured as a unipolar electrode to simultaneously obtain and record signals from the heart tissue.

7. The implantable lead of claim 6 , wherein the fixation helix and the wire configured as bipolar electrodes to obtain and record signals from the heart tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2020
From: LIU, LILI; FOSTER, ARTHUR J.; MILLER, MATTHEW J.
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 052168/0026 →
Continuity (2)
Provisional Application 62783916 · Dec 21, 2018
Related Publication 20200197693A1 · Jun 25, 2020
Cited By (1)
US 12,415,069